Dual Loading of Nanoparticles with Doxorubicin and Icotinib for the Synergistic Suppression of Non-Small Cell Lung Cancer

Background: Combination chemotherapy plays an important role in the clinical therapy of non-small cell lung cancer (NSCLC). However, the pharmacokinetic differences between drugs are an insurmountable barrier in traditional treatment. For the synergistic therapy of NSCLC, synergistic nanoparticles (...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ke, Zhan, Wenhua, Jia, Min, Zhao, Yufeng, Liu, Yingguang, Jha, Rajiv Kumar, Zhou, Liansuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053357/
https://www.ncbi.nlm.nih.gov/pubmed/32132874
http://dx.doi.org/10.7150/ijms.39172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053357/
https://www.ncbi.nlm.nih.gov/pubmed/32132874
http://dx.doi.org/10.7150/ijms.39172

Ejemplares similares